Special Issue "Coronavirus Disease 2019 (COVID-19) Pandemic: Current Knowledge and Future Perspectives"
Deadline for manuscript submissions: 28 February 2021.
(2) Sorbonne Université, Inserm, Centre de Recherche Saint Antoine (CRSA), Paris, France
Interests: pediatrics, respiratory diseases; respiratory infectious diseases; genetics; cystic fibrosis; phenomics; modifier genes; interstitial lung diseases; surfactant disorders; lung fibrosis; COVID-19; SARS-CoV-2
(2) Sorbonne Université, Inserm UMRS933, Paris, France
Interests: pediatrics, respiratory diseases; respiratory infectious diseases; genetics; interstitial lung diseases; surfactant disorders; pulmonary fibrosis; COVID-19; SARS-CoV-2
Since December 2019, the COVID-19 pandemic has spread over the world and there have been more than two million confirmed cases. This new coronavirus with a high degree of pathogenicity first infected China through an animal-to-human transmission. A few months later, thousands of patients worldwide need intensive care management and billions of individuals are living under national lockdowns. No one is spared from the medical, psychological, and economic ravages of this pandemic. International efforts of the scientific community are directed towards finding effective treatments and vaccine against SARS-CoV-2. In this Special Issue, we invite original research articles and state-of-the-art reviews focused on current knowledge and future perspectives on SARS-CoV-2 (including physiopathology, virology, biology, epidemiology, transmission, etc.); COVID-19 phenotypic expression (in the general population as well as in specific populations such as children); diagnostic and therapeutic approaches; biomarkers of disease severity and of treatment response, etc. We are also interested in studies and reviews evaluating the positive and negative effects of the various national crisis management approaches and their psychological impacts.
Prof. Dr. Harriet Corvol
Dr. Nadia Nathan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- diagnostic tools
- therapeutic perspectives
- psychological impact